I don't understand the disappointment. Four of eight patients with the mutation had responses at 54mg/kg. Now they are going up to 80 mg/kg in the next cohort. I think is a good result. Any opinions?
I reread the release. They also talked about " possible continued dose expansion" above 80 mg/kg.